Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Impact of Bacillus spp. spores and gentamicin on the gastrointestinal microbiota of suckling and newly weaned piglets.

Poulsen AR, Jonge N, Nielsen JL, Højberg O, Lauridsen C, Cutting SM, Canibe N.

PLoS One. 2018 Nov 27;13(11):e0207382. doi: 10.1371/journal.pone.0207382. eCollection 2018.

2.

Impact of early-life events on the susceptibility to Clostridium difficile colonisation and infection in the offspring of the pig.

Grześkowiak ŁM, Pieper R, Huynh HA, Cutting SM, Vahjen W, Zentek J.

Gut Microbes. 2019;10(2):251-259. doi: 10.1080/19490976.2018.1518554. Epub 2018 Sep 25.

3.

Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria.

Passmore IJ, Letertre MPM, Preston MD, Bianconi I, Harrison MA, Nasher F, Kaur H, Hong HA, Baines SD, Cutting SM, Swann JR, Wren BW, Dawson LF.

PLoS Pathog. 2018 Sep 12;14(9):e1007191. doi: 10.1371/journal.ppat.1007191. eCollection 2018 Sep.

4.

Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions.

Hoelzer K, Bielke L, Blake DP, Cox E, Cutting SM, Devriendt B, Erlacher-Vindel E, Goossens E, Karaca K, Lemiere S, Metzner M, Raicek M, Collell Suriñach M, Wong NM, Gay C, Van Immerseel F.

Vet Res. 2018 Jul 31;49(1):70. doi: 10.1186/s13567-018-0561-7. Review.

5.

Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs.

Hoelzer K, Bielke L, Blake DP, Cox E, Cutting SM, Devriendt B, Erlacher-Vindel E, Goossens E, Karaca K, Lemiere S, Metzner M, Raicek M, Collell Suriñach M, Wong NM, Gay C, Van Immerseel F.

Vet Res. 2018 Jul 31;49(1):64. doi: 10.1186/s13567-018-0560-8. Review.

6.

Baseline NIH Stroke Scale is an inferior predictor of functional outcome in the era of acute stroke intervention.

Reznik ME, Yaghi S, Jayaraman MV, McTaggart RA, Hemendinger M, Mac Grory BC, Burton TM, Cutting SM, Siket MS, Madsen TE, Thompson BB, Wendell LC, Mahta A, Potter NS, Furie KL.

Int J Stroke. 2018 Oct;13(8):806-810. doi: 10.1177/1747493018783759. Epub 2018 Jun 29.

PMID:
29956598
7.

Level of consciousness at discharge and associations with outcome after ischemic stroke.

Reznik ME, Yaghi S, Jayaraman MV, McTaggart RA, Hemendinger M, Mac Grory BC, Burton TM, Cutting SM, Thompson BB, Wendell LC, Mahta A, Potter NS, Daiello LA, Kosar CM, Jones RN, Furie KL.

J Neurol Sci. 2018 Jul 15;390:102-107. doi: 10.1016/j.jns.2018.04.022. Epub 2018 Apr 14.

PMID:
29801867
8.

Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin.

Copland A, Diogo GR, Hart P, Harris S, Tran AC, Paul MJ, Singh M, Cutting SM, Reljic R.

Front Immunol. 2018 Mar 12;9:346. doi: 10.3389/fimmu.2018.00346. eCollection 2018.

9.

Perfusion imaging and recurrent cerebrovascular events in intracranial atherosclerotic disease or carotid occlusion.

Sacchetti DC, Cutting SM, McTaggart RA, Chang AD, Hemendinger M, Mac Grory B, Siket MS, Burton T, Thompson B, Rostanski SK, Prabhakaran S, Willey JZ, Marshall RS, Elkind MS, Khatri P, Furie KL, Jayaraman MV, Yaghi S.

Int J Stroke. 2018 Aug;13(6):592-599. doi: 10.1177/1747493018764075. Epub 2018 Mar 5.

PMID:
29502498
10.

Predictors of symptomatic intracranial haemorrhage in patients with an ischaemic stroke with neurological deterioration after intravenous thrombolysis.

James B, Chang AD, McTaggart RA, Hemendinger M, Mac Grory B, Cutting SM, Burton TM, Reznik ME, Thompson B, Wendell L, Mahta A, Siket M, Madsen TE, Sheth KN, Nouh A, Furie KL, Jayaraman MV, Khatri P, Yaghi S.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):866-869. doi: 10.1136/jnnp-2017-317341. Epub 2018 Feb 27.

PMID:
29487169
11.

Left Atrial Appendage Morphology and Embolic Stroke of Undetermined Source: A Cross-Sectional Multicenter Pilot Study.

Yaghi S, Chang AD, Hung P, Mac Grory B, Collins S, Gupta A, Reynolds J, Finn CB, Hemendinger M, Cutting SM, McTaggart RA, Jayaraman M, Leasure A, Sansing L, Panda N, Song C, Chu A, Merkler A, Gialdini G, Sheth KN, Kamel H, Elkind MSV, Greer D, Furie K, Atalay M.

J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1497-1501. doi: 10.1016/j.jstrokecerebrovasdis.2017.12.036. Epub 2018 Feb 3.

PMID:
29398537
12.

Early Elevated Troponin Levels After Ischemic Stroke Suggests a Cardioembolic Source.

Yaghi S, Chang AD, Ricci BA, Jayaraman MV, McTaggart RA, Hemendinger M, Narwal P, Dakay K, Mac Grory B, Cutting SM, Burton TM, Song C, Mehanna E, Siket M, Madsen TE, Reznik M, Merkler AE, Lerario MP, Kamel H, Elkind MSV, Furie KL.

Stroke. 2018 Jan;49(1):121-126. doi: 10.1161/STROKEAHA.117.019395. Epub 2017 Nov 22. Erratum in: Stroke. 2018 Jan;49(1):e24.

PMID:
29167390
13.

Biological Containment of Genetically Modified Bacillus subtilis.

Hosseini S, Curilovs A, Cutting SM.

Appl Environ Microbiol. 2018 Jan 17;84(3). pii: e02334-17. doi: 10.1128/AEM.02334-17. Print 2018 Feb 1.

14.

Inducible Expression of spo0A as a Universal Tool for Studying Sporulation in Clostridium difficile.

Dembek M, Willing SE, Hong HA, Hosseini S, Salgado PS, Cutting SM.

Front Microbiol. 2017 Sep 21;8:1793. doi: 10.3389/fmicb.2017.01793. eCollection 2017.

15.

Beneficial effects of carotenoid-producing cells of Bacillus indicus HU16 in a rat model of diet-induced metabolic syndrome.

Crescenzo R, Mazzoli A, Cancelliere R, Bucci A, Naclerio G, Baccigalupi L, Cutting SM, Ricca E, Iossa S.

Benef Microbes. 2017 Oct 13;8(5):823-831. doi: 10.3920/BM2017.0025. Epub 2017 Oct 3.

PMID:
28969443
16.

The Spore Coat Protein CotE Facilitates Host Colonization by Clostridium difficile.

Hong HA, Ferreira WT, Hosseini S, Anwar S, Hitri K, Wilkinson AJ, Vahjen W, Zentek J, Soloviev M, Cutting SM.

J Infect Dis. 2017 Dec 12;216(11):1452-1459. doi: 10.1093/infdis/jix488.

17.

Erratum for Hong et al., "Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile".

Hong HA, Hitri K, Hosseini S, Kotowicz N, Bryan D, Mawas F, Wilkinson AJ, van Broekhoven A, Kearsey J, Cutting SM.

Infect Immun. 2017 May 23;85(6). pii: e00279-17. doi: 10.1128/IAI.00279-17. Print 2017 Jun. No abstract available.

18.

Association of a Primary Stroke Center Protocol for Suspected Stroke by Large-Vessel Occlusion With Efficiency of Care and Patient Outcomes.

McTaggart RA, Yaghi S, Cutting SM, Hemendinger M, Baird GL, Haas RA, Furie KL, Jayaraman MV.

JAMA Neurol. 2017 Jul 1;74(7):793-800. doi: 10.1001/jamaneurol.2017.0477.

19.

Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.

Hong HA, Hitri K, Hosseini S, Kotowicz N, Bryan D, Mawas F, Wilkinson AJ, van Broekhoven A, Kearsey J, Cutting SM.

Infect Immun. 2017 Mar 23;85(4). pii: e01060-16. doi: 10.1128/IAI.01060-16. Print 2017 Apr. Erratum in: Infect Immun. 2017 May 23;85(6):.

20.

Protection of Penaeus monodon against white spot syndrome by continuous oral administration of a low concentration of Bacillus subtilis spores expressing the VP28 antigen.

Pham KC, Tran HT, Van Doan C, Le PH, Van Nguyen AT, Nguyen HA, Hong HA, Cutting SM, Phan TN.

Lett Appl Microbiol. 2017 Mar;64(3):184-191. doi: 10.1111/lam.12708. Epub 2017 Feb 1.

PMID:
27992657
21.

Continuous aspiration prior to intracranial vascular embolectomy (CAPTIVE): a technique which improves outcomes.

McTaggart RA, Tung EL, Yaghi S, Cutting SM, Hemendinger M, Gale HI, Baird GL, Haas RA, Jayaraman MV.

J Neurointerv Surg. 2017 Dec;9(12):1154-1159. doi: 10.1136/neurintsurg-2016-012838. Epub 2016 Dec 16.

PMID:
27986848
22.

Boosting BCG with inert spores improves immunogenicity and induces specific IL-17 responses in a murine model of bovine tuberculosis.

Garcia-Pelayo MC, Kaveh DA, Sibly L, Webb PR, Bull NC, Cutting SM, Hogarth PJ.

Tuberculosis (Edinb). 2016 May;98:97-103. doi: 10.1016/j.tube.2016.03.004. Epub 2016 Mar 30.

23.

Increased toxin expression in a Clostridium difficile mfd mutant.

Willing SE, Richards EJ, Sempere L, Dale AG, Cutting SM, Fairweather NF.

BMC Microbiol. 2015 Dec 18;15:280. doi: 10.1186/s12866-015-0611-5.

24.

Annotation and functional assignment of the genes for the C30 carotenoid pathways from the genomes of two bacteria: Bacillus indicus and Bacillus firmus.

Steiger S, Perez-Fons L, Cutting SM, Fraser PD, Sandmann G.

Microbiology. 2015 Jan;161(Pt 1):194-202. doi: 10.1099/mic.0.083519-0. Epub 2014 Oct 17.

PMID:
25326460
25.

Bacterial spore-formers: friends and foes.

Cutting SM, Ricca E.

FEMS Microbiol Lett. 2014 Sep;358(2):107-9. doi: 10.1111/1574-6968.12572. Epub 2014 Aug 28. No abstract available.

26.

Bacillus subtilis spores expressing the VP28 antigen: a potential oral treatment to protect Litopenaeus vannamei against white spot syndrome.

Nguyen AT, Pham CK, Pham HT, Pham HL, Nguyen AH, Dang LT, Huynh HA, Cutting SM, Phan TN.

FEMS Microbiol Lett. 2014 Sep;358(2):202-8. doi: 10.1111/1574-6968.12546. Epub 2014 Aug 28.

27.

Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model.

Sibley L, Reljic R, Radford DS, Huang JM, Hong HA, Cranenburgh RM, Cutting SM.

FEMS Microbiol Lett. 2014 Sep;358(2):170-9. doi: 10.1111/1574-6968.12525. Epub 2014 Jul 22.

28.

Use of Bacillus subtilis PXN21 spores for suppression of Clostridium difficile infection symptoms in a murine model.

Colenutt C, Cutting SM.

FEMS Microbiol Lett. 2014 Sep;358(2):154-61. doi: 10.1111/1574-6968.12468. Epub 2014 May 29.

29.

The spore-associated protein BclA1 affects the susceptibility of animals to colonization and infection by Clostridium difficile.

Phetcharaburanin J, Hong HA, Colenutt C, Bianconi I, Sempere L, Permpoonpattana P, Smith K, Dembek M, Tan S, Brisson MC, Brisson AR, Fairweather NF, Cutting SM.

Mol Microbiol. 2014 Jun;92(5):1025-38. doi: 10.1111/mmi.12611. Epub 2014 Apr 24.

30.

Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.

Stylianou E, Diogo GR, Pepponi I, van Dolleweerd C, Arias MA, Locht C, Rider CC, Sibley L, Cutting SM, Loxley A, Ma JK, Reljic R.

Eur J Immunol. 2014 Feb;44(2):440-9.

31.

In pursuit of protein targets: proteomic characterization of bacterial spore outer layers.

Abhyankar W, Hossain AH, Djajasaputra A, Permpoonpattana P, Ter Beek A, Dekker HL, Cutting SM, Brul S, de Koning LJ, de Koster CG.

J Proteome Res. 2013 Oct 4;12(10):4507-21. doi: 10.1021/pr4005629. Epub 2013 Sep 23.

PMID:
23998435
32.

Mucosal vaccination against tuberculosis using inert bioparticles.

Reljic R, Sibley L, Huang JM, Pepponi I, Hoppe A, Hong HA, Cutting SM.

Infect Immun. 2013 Nov;81(11):4071-80. doi: 10.1128/IAI.00786-13. Epub 2013 Aug 19.

33.

Killed Bacillus subtilis spores expressing streptavidin: a novel carrier of drugs to target cancer cells.

Nguyen VA, Huynh HA, Hoang TV, Ninh NT, Pham AT, Nguyen HA, Phan TN, Cutting SM.

J Drug Target. 2013 Jul;21(6):528-41. doi: 10.3109/1061186X.2013.778262. Epub 2013 Mar 12.

PMID:
23480726
34.

Functional characterization of Clostridium difficile spore coat proteins.

Permpoonpattana P, Phetcharaburanin J, Mikelsone A, Dembek M, Tan S, Brisson MC, La Ragione R, Brisson AR, Fairweather N, Hong HA, Cutting SM.

J Bacteriol. 2013 Apr;195(7):1492-503. doi: 10.1128/JB.02104-12. Epub 2013 Jan 18.

35.

Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine.

Song M, Hong HA, Huang JM, Colenutt C, Khang DD, Nguyen TV, Park SM, Shim BS, Song HH, Cheon IS, Jang JE, Choi JA, Choi YK, Stadler K, Cutting SM.

Vaccine. 2012 May 9;30(22):3266-77. doi: 10.1016/j.vaccine.2012.03.016. Epub 2012 Mar 22.

PMID:
22446640
36.

Evaluation of Bacillus subtilis strains as probiotics and their potential as a food ingredient.

Permpoonpattana P, Hong HA, Khaneja R, Cutting SM.

Benef Microbes. 2012 Jun 1;3(2):127-35. doi: 10.3920/BM2012.0002.

PMID:
22433662
37.

Surface layers of Clostridium difficile endospores.

Permpoonpattana P, Tolls EH, Nadem R, Tan S, Brisson A, Cutting SM.

J Bacteriol. 2011 Dec;193(23):6461-70. doi: 10.1128/JB.05182-11. Epub 2011 Sep 23.

38.

Carbohydrate-active enzymes from pigmented Bacilli: a genomic approach to assess carbohydrate utilization and degradation.

Manzo N, D'Apuzzo E, Coutinho PM, Cutting SM, Henrissat B, Ricca E.

BMC Microbiol. 2011 Sep 5;11:198. doi: 10.1186/1471-2180-11-198.

39.

Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B.

Permpoonpattana P, Hong HA, Phetcharaburanin J, Huang JM, Cook J, Fairweather NF, Cutting SM.

Infect Immun. 2011 Jun;79(6):2295-302. doi: 10.1128/IAI.00130-11. Epub 2011 Apr 11.

40.

Bacillus probiotics.

Cutting SM.

Food Microbiol. 2011 Apr;28(2):214-20. doi: 10.1016/j.fm.2010.03.007. Epub 2010 Mar 24. Review.

PMID:
21315976
41.

Identification and the developmental formation of carotenoid pigments in the yellow/orange Bacillus spore-formers.

Perez-Fons L, Steiger S, Khaneja R, Bramley PM, Cutting SM, Sandmann G, Fraser PD.

Biochim Biophys Acta. 2011 Mar;1811(3):177-85. doi: 10.1016/j.bbalip.2010.12.009. Epub 2011 Jan 5.

PMID:
21215325
42.

Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector.

Huang JM, Sali M, Leckenby MW, Radford DS, Huynh HA, Delogu G, Cranenburgh RM, Cutting SM.

Vaccine. 2010 Nov 3;28(47):7523-8. doi: 10.1016/j.vaccine.2010.09.001. Epub 2010 Sep 17.

PMID:
20851079
43.

Oral vaccine delivery by recombinant spore probiotics.

Cutting SM, Hong HA, Baccigalupi L, Ricca E.

Int Rev Immunol. 2009;28(6):487-505. doi: 10.3109/08830180903215605. Review.

PMID:
19954360
44.

Mucosal delivery of antigens using adsorption to bacterial spores.

Huang JM, Hong HA, Van Tong H, Hoang TH, Brisson A, Cutting SM.

Vaccine. 2010 Jan 22;28(4):1021-30. doi: 10.1016/j.vaccine.2009.10.127. Epub 2009 Nov 13.

PMID:
19914191
45.

Carotenoids found in Bacillus.

Khaneja R, Perez-Fons L, Fakhry S, Baccigalupi L, Steiger S, To E, Sandmann G, Dong TC, Ricca E, Fraser PD, Cutting SM.

J Appl Microbiol. 2010 Jun;108(6):1889-902. doi: 10.1111/j.1365-2672.2009.04590.x. Epub 2009 Oct 15.

46.

Defining the natural habitat of Bacillus spore-formers.

Hong HA, To E, Fakhry S, Baccigalupi L, Ricca E, Cutting SM.

Res Microbiol. 2009 Jul-Aug;160(6):375-9. doi: 10.1016/j.resmic.2009.06.006. Epub 2009 Jul 7.

PMID:
19589385
47.

The effect of anti-spore antibody responses on the use of spores for vaccine delivery.

Yu LH, Cutting SM.

Vaccine. 2009 Jul 23;27(34):4576-84. doi: 10.1016/j.vaccine.2009.05.087. Epub 2009 Jun 17.

PMID:
19539577
48.

Searching for protein-protein interactions within the Bacillus subtilis spore coat.

Krajcíková D, Lukácová M, Müllerová D, Cutting SM, Barák I.

J Bacteriol. 2009 May;191(10):3212-9. doi: 10.1128/JB.01807-08. Epub 2009 Mar 20.

49.

Bacillus subtilis isolated from the human gastrointestinal tract.

Hong HA, Khaneja R, Tam NM, Cazzato A, Tan S, Urdaci M, Brisson A, Gasbarrini A, Barnes I, Cutting SM.

Res Microbiol. 2009 Mar;160(2):134-43. doi: 10.1016/j.resmic.2008.11.002. Epub 2008 Nov 28.

PMID:
19068230
50.

Cytoplasmic delivery of antigens, by Bacillus subtilis enhances Th1 responses.

Huang JM, La Ragione RM, Cooley WA, Todryk S, Cutting SM.

Vaccine. 2008 Nov 11;26(48):6043-52. doi: 10.1016/j.vaccine.2008.09.024. Epub 2008 Sep 20.

PMID:
18809450

Supplemental Content

Loading ...
Support Center